Literature DB >> 11036168

Plasma cortisol levels in elderly female subjects with Alzheimer's disease: a cross-sectional and longitudinal study.

H Umegaki1, H Ikari, H Nakahata, H Endo, Y Suzuki, O Ogawa, A Nakamura, T Yamamoto, A Iguchi.   

Abstract

We investigated the plasma cortisol levels at a fasting state in elderly female Alzheimer's disease (AD), vascular dementia (VD), and non-demented subjects (n=66, 28 and 21, respectively). Twenty-eight AD subjects were followed for 40 months. The plasma cortisol levels in AD and VD subjects were significantly higher than those of non-demented subjects at baseline. In AD subjects in relatively early stages of the disease [Mini-Mental State Examination (MMSE)], at baseline, high plasma cortisol led to rapid declines in MMSE scores over a 40-month period.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11036168     DOI: 10.1016/s0006-8993(00)02847-x

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  25 in total

1.  Corticotrophin releasing factor accelerates neuropathology and cognitive decline in a mouse model of Alzheimer's disease.

Authors:  Hongxin Dong; Keely M Murphy; Liping Meng; Janitza Montalvo-Ortiz; Ziling Zeng; Benedict J Kolber; Shanshan Zhang; Louis J Muglia; John G Csernansky
Journal:  J Alzheimers Dis       Date:  2012       Impact factor: 4.472

2.  Glucocorticoids increase amyloid-beta and tau pathology in a mouse model of Alzheimer's disease.

Authors:  Kim N Green; Lauren M Billings; Benno Roozendaal; James L McGaugh; Frank M LaFerla
Journal:  J Neurosci       Date:  2006-08-30       Impact factor: 6.167

3.  The effects of hormones of the hypothalamo-hypophyseal-adrenal, renin-angiotensin, and thyroid hormone systems on the formation of dyscirculatory encephalopathy.

Authors:  V I Skvortsova; I A Platonova; T V Tvorogova; O V Volkovenko; L I Demidova; I V Ostrovtsev
Journal:  Neurosci Behav Physiol       Date:  2004-11

4.  Effects of corticotrophin-releasing factor receptor 1 antagonists on amyloid-β and behavior in Tg2576 mice.

Authors:  Hongxin Dong; Shirlene Wang; Ziling Zeng; Fei Li; Janitza Montalvo-Ortiz; Christopher Tucker; Shahzad Akhtar; Jingshan Shi; Herbert Y Meltzer; Kenner C Rice; John G Csernansky
Journal:  Psychopharmacology (Berl)       Date:  2014-05-27       Impact factor: 4.530

5.  Short-term modern life-like stress exacerbates Aβ-pathology and synapse loss in 3xTg-AD mice.

Authors:  David Baglietto-Vargas; Yuncai Chen; Dongjin Suh; Rahasson R Ager; Carlos J Rodriguez-Ortiz; Rodrigo Medeiros; Kristoffer Myczek; Kim N Green; Tallie Z Baram; Frank M LaFerla
Journal:  J Neurochem       Date:  2015-07-14       Impact factor: 5.372

6.  3xTgAD mice exhibit altered behavior and elevated Aβ after chronic mild social stress.

Authors:  Sarah M Rothman; Nathan Herdener; Simonetta Camandola; Sarah J Texel; Mohamed R Mughal; Wei-Na Cong; Bronwen Martin; Mark P Mattson
Journal:  Neurobiol Aging       Date:  2011-08-19       Impact factor: 4.673

7.  Chronic mild sleep restriction accentuates contextual memory impairments, and accumulations of cortical Aβ and pTau in a mouse model of Alzheimer's disease.

Authors:  Sarah M Rothman; Nathan Herdener; Kathryn A Frankola; Mohamed R Mughal; Mark P Mattson
Journal:  Brain Res       Date:  2013-07-13       Impact factor: 3.252

Review 8.  Sexual dimorphism in predisposition to Alzheimer's disease.

Authors:  Daniel W Fisher; David A Bennett; Hongxin Dong
Journal:  Neurobiol Aging       Date:  2018-04-17       Impact factor: 4.673

Review 9.  Adverse stress, hippocampal networks, and Alzheimer's disease.

Authors:  Sarah M Rothman; Mark P Mattson
Journal:  Neuromolecular Med       Date:  2009-11-27       Impact factor: 3.843

10.  Mifepristone alters amyloid precursor protein processing to preclude amyloid beta and also reduces tau pathology.

Authors:  David Baglietto-Vargas; Rodrigo Medeiros; Hilda Martinez-Coria; Frank M LaFerla; Kim N Green
Journal:  Biol Psychiatry       Date:  2013-01-08       Impact factor: 13.382

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.